ESTRO 35 Abstract book

Symposium with Proffered Papers

Plan of the day (PotD): current status (Abs. 619-621)

Debate

We don’t need better dose calculation, it’s doing more bad than good (Abs. 622-623)

Are we precisely inaccurate in our adaption? (Abs. 624-625)

Moving away from 2 Gray: are we ready for a paradigm shift? (Abs. 626-629)

Posters

Clinical track: Head and neck (Abs. 630-640)

Clinical track: CNS (Abs. 641-661)

Clinical track: Haematology (Abs. 662-671)

Clinical track: Breast (Abs. 672-677)

Clinical track: Lung (Abs. 678-695)

Clinical track: Upper GI (oesophagus, stomach, pancreas, liver) (Abs. 696-714)

Clinical track: Lower GI (colon, rectum, anus) (Abs. 715-722)

Clinical track: Gynaecological (endometrium, cervix, vagina, vulva) (Abs. 723-735)

Clinical track: Prostate (Abs. 736-758)

Clinical track: Urology-non-prostate (Abs. 759-760)

Clinical track: Skin cancer / malignant melanoma (Abs. 761-763)

Clinical track: Sarcoma (Abs. 764-768)

Clinical track: Paediatric tumours (Abs. 769-771)

Clinical track: Palliation (Abs. 772-779)

Clinical track: Elderly (Abs. 780-782)